ArticleFrontiers in pharmacology2019

Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies.

Shu-Ping Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.